Literature DB >> 1583354

Overexpression of c-Ki-ras and c-fos in human pancreatic carcinomas.

K Wakita1, H Ohyanagi, K Yamamoto, T Tokuhisa, Y Saitoh.   

Abstract

The mRNA expression of protooncogenes c-Ki-ras, c-myc, and c-fos was studied in five pancreatic carcinomas and five normal pancreatic tissues using RNase protection assay and Northern blot analysis. The expression of those protooncogenes was detected in total mRNA from all specimens. However, the amounts in carcinomas and in normal tissues differed. C-Ki-ras mRNA in all the tumors was expressed up to sixfold more than in normal tissues. C-fos mRNA was also overexpressed up to tenfold in four of five tumors. In contrast, c-myc mRNA levels were varied and did not differ significantly between tumors and normal tissues. The results suggest that the overexpression of c-Ki-ras and c-fos mRNA are implicated in the development of pancreatic adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1583354     DOI: 10.1007/bf02925993

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  20 in total

1.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

2.  Direct sequencing analysis of exon 1 of the c-K-ras gene shows a low frequency of mutations in human pancreatic adenocarcinomas.

Authors:  N F Gonzalez-Cadavid; D Zhou; H Battifora; M Bar-Eli; M J Cline
Journal:  Oncogene       Date:  1989-09       Impact factor: 9.867

3.  KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas.

Authors:  V T Smit; A J Boot; A M Smits; G J Fleuren; C J Cornelisse; J L Bos
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

4.  The c-erb B-2 proto-oncogene in human pancreatic cancer.

Authors:  P A Hall; C M Hughes; S L Staddon; P I Richman; W J Gullick; N R Lemoine
Journal:  J Pathol       Date:  1990-07       Impact factor: 7.996

5.  Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes.

Authors:  H Yamada; H Sakamoto; M Taira; S Nishimura; Y Shimosato; M Terada; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1986-04

6.  Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissues.

Authors:  M Shimizu; Y Saitoh; H Itoh
Journal:  Hum Pathol       Date:  1990-06       Impact factor: 3.466

7.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

8.  Human colon carcinoma Ki-ras2 oncogene and its corresponding proto-oncogene.

Authors:  M S McCoy; C I Bargmann; R A Weinberg
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

9.  Amplification of c-Ki-ras-2 oncogene sequences in human carcinoma of pancreas.

Authors:  I Parsa; P M Pour; C M Cleary
Journal:  Int J Pancreatol       Date:  1988 Jan-Feb

10.  Clinical implications of oncogene activation in human neuroblastomas.

Authors:  G M Brodeur; R C Seeger; H Sather; A Dalton; S E Siegel; K Y Wong; D Hammond
Journal:  Cancer       Date:  1986-07-15       Impact factor: 6.860

View more
  6 in total

1.  RGS16 and FosB underexpressed in pancreatic cancer with lymph node metastasis promote tumor progression.

Authors:  Ji Hyang Kim; Jin Young Lee; Kyu Taek Lee; Jong Kyoon Lee; Kwang Hyuck Lee; Kee-Taek Jang; Jin Seok Heo; Seong Ho Choi; Jong Chul Rhee
Journal:  Tumour Biol       Date:  2010-06-23

Review 2.  The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis.

Authors:  S R Bramhall
Journal:  Int J Pancreatol       Date:  1998-04

3.  Prognostic significance of loss of c-fos protein in gastric carcinoma.

Authors:  Seon Pil Jin; Ji Hun Kim; Min A Kim; Han-Kwang Yang; Hee Eun Lee; Hye Seung Lee; Woo Ho Kim
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

4.  Activator protein-1 has an essential role in pancreatic cancer cells and is regulated by a novel Akt-mediated mechanism.

Authors:  Sonyo Shin; Takayuki Asano; Yixin Yao; Ronghua Zhang; Francois-Xavier Claret; Murray Korc; Kanaga Sabapathy; David G Menter; James L Abbruzzese; Shrikanth A G Reddy
Journal:  Mol Cancer Res       Date:  2009-05-12       Impact factor: 5.852

Review 5.  Microarray-based gene expression profiling in pancreatic ductal carcinoma: status quo and perspectives.

Authors:  Robert Grützmann; Hans Detlev Saeger; Jutta Lüttges; Hans Konrad Schackert; Holger Kalthoff; Günter Klöppel; Christian Pilarsky
Journal:  Int J Colorectal Dis       Date:  2004-01-24       Impact factor: 2.571

6.  The active role of the transcription factor Sp1 in NFATc2-mediated gene regulation in pancreatic cancer.

Authors:  Manuela Malsy; Bernhard Graf; Katrin Almstedt
Journal:  BMC Biochem       Date:  2019-01-29       Impact factor: 4.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.